These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 2072661

  • 21. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H, Yoo TM, Drumm D, Kim MK, Sun BF, Le N, Webber KO, Pastan I, Waldmann TA, Paik CH, Carrasquillo JA.
    Cancer Res; 1997 May 15; 57(10):1955-61. PubMed ID: 9157991
    [Abstract] [Full Text] [Related]

  • 22. Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam.
    Ruan S, O'Donoghue JA, Larson SM, Finn RD, Jungbluth A, Welt S, Humm JL.
    J Nucl Med; 2000 Nov 15; 41(11):1905-12. PubMed ID: 11079503
    [Abstract] [Full Text] [Related]

  • 23. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
    Katari RS, Fernsten PD, Schlom J.
    Cancer Res; 1990 Aug 15; 50(16):4885-90. PubMed ID: 2379152
    [Abstract] [Full Text] [Related]

  • 24. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I.
    Cancer Res; 1993 Jan 01; 53(1):94-100. PubMed ID: 8093231
    [Abstract] [Full Text] [Related]

  • 25. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV, Zalutsky MR, Archer GE, Noska MA, Friedman HS, Carrel S, Bigner DD.
    Cancer Res; 1990 Mar 15; 50(6):1822-7. PubMed ID: 2407345
    [Abstract] [Full Text] [Related]

  • 26. Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin system.
    Kobayashi H, Sun BF, Yoo TM, Le N, Kim MK, Paik CH, Pastan I, Waldmann TA, Carrasquillo JA.
    J Nucl Med; 1999 Aug 15; 40(8):1381-91. PubMed ID: 10450692
    [Abstract] [Full Text] [Related]

  • 27. Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice.
    Zou P, Xu S, Povoski SP, Wang A, Johnson MA, Martin EW, Subramaniam V, Xu R, Sun D.
    Mol Pharm; 2009 Aug 15; 6(2):428-40. PubMed ID: 19718796
    [Abstract] [Full Text] [Related]

  • 28. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts.
    Kennel SJ, Falcioni R, Wesley JW.
    Cancer Res; 1991 Mar 01; 51(5):1529-36. PubMed ID: 1997194
    [Abstract] [Full Text] [Related]

  • 29. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors.
    Sung C, Shockley TR, Morrison PF, Dvorak HF, Yarmush ML, Dedrick RL.
    Cancer Res; 1992 Jan 15; 52(2):377-84. PubMed ID: 1728409
    [Abstract] [Full Text] [Related]

  • 30. Immunotargeting of human small cell lung cancer xenografts in athymic mice using a monoclonal antibody (RNL-1) against a neuroendocrine-related antigen.
    Mijnheere EP, Boerman OC, Broers JL, Klein Rot M, Vooijs GP, Ramaekers FC.
    Br J Cancer Suppl; 1991 Jun 15; 14():78-81. PubMed ID: 1645579
    [Abstract] [Full Text] [Related]

  • 31. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
    Rogers BE, Roberson PL, Shen S, Khazaeli MB, Carpenter M, Yokoyama S, Brechbiel MW, LoBuglio AF, Buchsbaum DJ.
    Cancer Biother Radiopharm; 2005 Oct 15; 20(5):502-13. PubMed ID: 16248766
    [Abstract] [Full Text] [Related]

  • 32. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5.
    Lopes AD, Davis WL, Rosenstraus MJ, Uveges AJ, Gilman SC.
    Cancer Res; 1990 Oct 01; 50(19):6423-9. PubMed ID: 1698122
    [Abstract] [Full Text] [Related]

  • 33. Application of anti lung adenocarcinoma monoclonal antibody recognizing cytokeratin-like cytoplasmic antigen for tumor diagnosis.
    Shitara K, Fujiwara K, Kusano A, Yamaguchi K, Yoshida H, Sato S, Hanai N.
    Anticancer Res; 1992 Oct 01; 12(4):1121-9. PubMed ID: 1503402
    [Abstract] [Full Text] [Related]

  • 34. Radiolocalization of 99mTc-labeled fragments in a melanoma xenografted model.
    Paganelli G, Viale G, Rossetti C, Magnani P, Sudati F, Vanoli G, Seccamani E, Palmucci F, Fazio F.
    J Nucl Biol Med (1991); 1991 Oct 01; 35(1):41-6. PubMed ID: 1932175
    [Abstract] [Full Text] [Related]

  • 35. Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates.
    Schott ME, Schlom J, Siler K, Milenic DE, Eggensperger D, Colcher D, Cheng R, Kruper WJ, Fordyce W, Goeckeler W.
    Cancer; 1994 Feb 01; 73(3 Suppl):993-8. PubMed ID: 8306291
    [Abstract] [Full Text] [Related]

  • 36. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.
    Nieroda CA, Milenic DE, Carrasquillo JA, Scholm J, Greiner JW.
    Cancer Res; 1995 Jul 01; 55(13):2858-65. PubMed ID: 7796413
    [Abstract] [Full Text] [Related]

  • 37. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier.
    Juweid M, Neumann R, Paik C, Perez-Bacete MJ, Sato J, van Osdol W, Weinstein JN.
    Cancer Res; 1992 Oct 01; 52(19):5144-53. PubMed ID: 1327501
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics and tumor localization of (111)in-labeled HuCC49DeltaC(H)2 in BALB/c mice and athymic murine colon carcinoma xenograft.
    Chinn PC, Morena RA, Santoro DA, Kazules T, Kashmiri SV, Schlom J, Hanna N, Braslawsky G.
    Cancer Biother Radiopharm; 2006 Apr 01; 21(2):106-16. PubMed ID: 16706631
    [Abstract] [Full Text] [Related]

  • 39. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery.
    Kim JC, Roh SA, Koo KH, Ryu JH, Hong HK, Oh SJ, Ryu JS, Kim HJ, Bodmer WF.
    Int J Cancer; 2002 Feb 01; 97(4):542-7. PubMed ID: 11802220
    [Abstract] [Full Text] [Related]

  • 40. Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
    Kashmiri SV, Shu L, Padlan EA, Milenic DE, Schlom J, Hand PH.
    Hybridoma; 1995 Oct 01; 14(5):461-73. PubMed ID: 8575795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.